Rajeev Mathur

Head – Global Regulatory & Business Continuity
Sun Pharma

Rajeev Mathur works as Senior Vice President & Head – Global Regulatory and Business Continuity and Heads Global Pharmacovigilance at Sun Pharmaceutical Industries Limited (Sun Pharma).

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company with global revenues of over US$ 5 billion with more than 40 manufacturing facilities. We provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.

At Sun Pharma, Rajeev oversees branded and generic regulatory operations for global markets (API and Dosage forms) including regulatory support to operations as a part of business continuity. In addition, he also leads Global Pharmacovigilance.

Rajeev is a post graduate in Pharmaceutics & gold medallist from Delhi University and has extensive experience in development of dosage forms and managing regulatory operations. He has a vast exposure to global regulators including FDA, USA; EMA, HPRA, Ireland; MHRA, UK; TGA, Australia; MHLW, Japan; HSA, Singapore; ANVISA, Brazil; TPD, Canada; SAPHRA, South Africa; CDSCO, India and is focussed on delivering regulatory excellence to the organization and trusted partnership with regulatory authorities.

Rajeev foresees regulatory organization as a strategic partner to R&D and operations and believes in being business enabler with focus on documentation & compliance.

His other interest include Indian classical music and reading.

Early bird tickets
available now